Neurofilament light chain serum levels as a possible paclitaxel-induced peripheral neurotoxicity biomarker: Pilot and feasibility study

被引：0
|
作者：
Alberti, Paola [1 ]
Cicchiello, Federica [2 ]
Riva, Francesca [2 ]
Cazzaniga, Marina [1 ,2 ]
机构：
[1] Univ Milano Bicocca, Monza, Italy
[2] San Gerardo Hosp, Med Oncol Unit, Monza, Italy
来源：
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2020年 / 25卷 / 04期
关键词：
Taxane-induced peripheral neurotoxicity; NfL serum levels; surrogate biomarkers;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
133
引用
收藏
页码：481 / 482
页数：2
相关论文
共 50 条
  • [21] Neurofilament light chain as a biomarker of chemotherapy-induced peripheral neuropathy
    Andersen, Nanna E.
    Boehmerle, Wolfgang
    Huehnchen, Petra
    Stage, Tore B.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2024, 45 (10) : 872 - 879
  • [22] Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel- NeuroDeRisk project
    Balayssac, David
    Busserolles, Jerome
    Broto, Catherine
    Dalbos, Cristelle
    Prival, Laetitia
    Lamoine, Sylvain
    Richard, Damien
    Quintana, Mercedes
    Herbet, Aurelia
    Hilairet, Sandrine
    Hu, Yang
    Loryan, Irena
    Glaab, Warren E.
    Micheli, Laura
    Ghelardini, Carla
    Mannelli, Lorenzo Di Cesare
    Perrault, Olivier
    Slaoui, Mohamed
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 167
  • [23] Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy
    Cavaletti, Guido
    Pizzamiglio, Chiara
    Man, Albert
    Engber, Thomas M.
    Comi, Cristoforo
    Wilbraham, Darren
    CANCERS, 2023, 15 (17)
  • [24] Plasma neurofilament light chain levels in chemotherapy-induced peripheral neurotoxicity according to type of anticancer drug
    Velasco, Roser
    Marco, Carla
    Domingo-Domenech, Eva
    Stradella, Agostina
    Santos, Cristina
    Laquente, Berta
    Ferrer, German
    Argyriou, Andreas A.
    Bruna, Jordi
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (09)
  • [25] The Role of Serum Levels of Neurofilament Light (NfL) Chain as a Biomarker in Friedreich Ataxia
    Frempong, Bernice
    Wilson, Robert B.
    Schadt, Kimberly
    Lynch, David R.
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [26] Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies
    Mariotto, Sara
    Farinazzo, Alessia
    Magliozzi, Roberta
    Alberti, Daniela
    Monaco, Salvatore
    Ferrari, Sergio
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (03) : 174 - 177
  • [27] Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy
    Meregalli, Cristina
    Fumagalli, Giulia
    Alberti, Paola
    Canta, Annalisa
    Carozzi, Valentina Alda
    Chiorazzi, Alessia
    Monza, Laura
    Pozzi, Eleonora
    Sandelius, Asa
    Blennow, Kaj
    Zetterberg, Henrik
    Marmiroli, Paola
    Cavaletti, Guido
    EXPERIMENTAL NEUROLOGY, 2018, 307 : 129 - 132
  • [28] Efficacy and Safety of Mirogabalin Therapy for Paclitaxel-Induced Peripheral Neuropathy (MICHEL Study): A Pilot Study
    Sawa, Aya
    Bando, Hiroko
    Sato, Riko
    Matsuo, Tomohei
    Okazaki, Mai
    Hashimoto, Sachie
    Iguchi-Manaka, Akiko
    Hara, Hisato
    ONCOLOGY, 2025,
  • [29] Neurofilament light chain levels as an early predictive biomarker of neurotoxicity after CAR T-cell therapy
    Larue, Marion
    Bouvier, Amelie
    Maillard, Alexis
    Cuffel, Alexis
    Allain, Vincent
    Ursu, Renata
    Carpentier, Antoine F.
    Azoulay, Elie
    Thieblemont, Catherine
    Di Blasi, Roberta
    Caillat-Zucman, Sophie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (09)
  • [30] Serum Neurofilament Light-Chain Levels in Essential Tremor: A Replication Study
    Louis, Elan D.
    Sharma, Vibhash D.
    Hajjar, Ihab
    Hernandez, Nora
    NEURODEGENERATIVE DISEASES, 2024,
12345